SOCS and diabetes--ups and downs of a turbulent relationship

Dariusz Suchy1, Krzysztof Łabuzek, Grzegorz Machnik

  • 1Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland. dariuszsuchy@gmail.com

Insights

Suppressors of cytokine signalling (SOCS) proteins influence insulin resistance and diabetes development. Research highlights their role in type 1 and type 2 diabetes and related complications, suggesting therapeutic potential.

Area of Science:

  • Endocrinology
  • Immunology
  • Molecular Biology

Background:

  • Diabetes mellitus (T1D and T2D) poses a global health threat, necessitating deeper mechanistic understanding and improved treatments.
  • Suppressors of cytokine signalling (SOCS) proteins, initially identified as cytokine pathway inhibitors, exhibit broader roles.
  • SOCS proteins are increasingly recognized for their involvement in metabolic regulation and immune responses relevant to diabetes.

Purpose of the Study:

  • To review the multifaceted roles of SOCS proteins in the pathogenesis of type 1 and type 2 diabetes.
  • To explore the involvement of SOCS proteins in diabetes-related complications.
  • To summarize recent findings on the therapeutic potential of modulating SOCS proteins for diabetes treatment.

Main Methods:

  • Literature review of studies published in the last decade.
  • Analysis of research on SOCS protein function in models of T1D and T2D.
  • Examination of data linking SOCS proteins to insulin resistance, beta-cell function, and diabetes complications.

Main Results:

  • SOCS proteins modulate beta-cell mass and survival in T1D, enhancing graft survival.
  • In T2D and insulin resistance, SOCS proteins mediate signals from diabetogenic substances and regulate insulin receptor function.
  • SOCS proteins are implicated in diabetes complications, including retinopathy, nephropathy, and cardiomyopathy.

Conclusions:

  • SOCS proteins are critical regulators in both T1D and T2D pathogenesis and progression.
  • Modulating SOCS proteins presents a potential therapeutic strategy for diabetes and its complications.
  • Further research is warranted to reconcile inconsistent findings and fully elucidate SOCS-diabetes interactions.

Related Concept Videos

Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...